If you have taken Lipodrene and experienced adverse health effects, you might be eligible to file a lawsuit. The popular dietary supplement Lipodrene, which contains ephedra extract, has been linked to serious side effects and health risks.
This article provides detailed information about the legal actions being taken against the manufacturers of Lipodrene, the potential health risks associated with its use, and what you can do if you have been affected.
Table Of Contents
What is The Weight Loss Supplement Lipodrene Recall?
The weight loss supplement Lipodrene recall is focused on Lot # 001211197, Exp. 12/25 of Lipodrene with 25mg Ephedra Extract Dietary Supplement, manufactured by Hi Tech Pharmaceuticals Inc., according to the U.S. Food & Drug Administration (FDA) [1].
“The FDA has warned that DMAA is dangerous because it can narrow blood vessels and arteries and cause a corresponding rise in blood pressure or other cardiovascular problems, such as Shortness of breath, Arrhythmias, Elevated blood pressure, Tightening in the chest, and Heart attack,” the agency said.
This recall was initiated after an FDA analysis detected the presence of DMAA in one lot of Lipodrene. These supplements were purchased and distributed through wholesale and direct sales in the U.S. and Puerto Rico as a weight loss product, as well as online sales for both personal use and retail.
If you have purchased any dietary supplements affected by this recall, you should not take them. Instead, dispose of them or return them to the point of purchase for a refund.
The recall began on May 12, 2021.
Related Article: DMAA Safety Issues Lawsuit
What is the FDA Doing to Remove Hi-Tech Pharmaceuticals DMAA Products from the Market?
The FDA is actively implementing a variety of methods to remove Hi-Tech pharmaceuticals DMAA products from the market.
Starting in 2012, the FDA issued warning letters to companies, informing them that marketing DMAA-containing products violated U.S. law. During facility inspections, the FDA gave companies the chance to recall and destroy products containing DMAA voluntarily. When firms refuse to comply, the FDA took further action.
In 2013, the FDA detained two DMAA-containing products, OxyElite Pro and Jack3d, after USPLabs declined to comply voluntarily. Consequently, USPLabs was forced to destroy these products, valued at over $8 million, and agreed to cease manufacturing with DMAA.
Also,, in 2013, the FDA seized DMAA-containing products from Hi-Tech Pharmaceuticals. In April 2017, a federal district court ruled that these products were adulterated and ordered them condemned and forfeited to the United States for destruction.
In 2019, the U.S. Court of Appeals for the 11th Circuit upheld the lower court ruling, affirming that DMAA is not generally recognized as safe, and ordered the seized products to be condemned and forfeited. The Supreme Court denied a request from Hi-Tech Pharmaceuticals to review the case in 2020, and the products were destroyed in November 2020.
The Federal Trade Commission has also been involved in pursuing legal actions against marketers of weight-loss and health-related supplements for deceptive practices.
These actions demonstrate the FDA’s commitment to removing DMAA products from the market to protect consumer health.
Related Articles:
See all related dangerous drugs lawsuits our attorneys covered so far.
Do I Have a Lipodrene Lawsuit?
The Products Liability Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lipodrene Lawsuits. We are handling individual litigation nationwide and are currently accepting new injury and death cases in all 50 states.
If the side effects of Lipodrene harmed you or another loved one, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit, and we can help.